- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07943338
Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital (SATISCHOL)
A Prospective Observational Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital
SATISCHOL is a prospective, monocentric observational study designed to assess pain management and quality of care in patients undergoing elective cholecystectomy at Limoges University Hospital, France.
The primary objective is to assess the proportion of patients reporting a visual analogue scale (VAS) pain score below 4 two hours after surgery, in association with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.
Secondary objectives include assessing early postoperative pain, describing postoperative complications and intraoperative pain management techniques, and evaluating changes in patients' quality of life using the Gastrointestinal Quality of Life Index (GIQLI) and EQ-5D-5L questionnaires. Patient-reported experience will also be assessed using a study-specific questionnaire (PREMS).
A total of 70 participants are expected to be enrolled. Patients will be followed for approximately 3 to 6 weeks after surgery.
Обзор исследования
Статус
Подробное описание
Cholecystectomy is one of the most frequently performed surgical procedures worldwide, both in elective and emergency settings. At Limoges University Hospital, 146 elective laparoscopic cholecystectomies were performed in 2024.
Cholecystectomy is indicated for the treatment of various biliary tract conditions, including biliary colic, acute or chronic cholecystitis, gallbladder polyps, gallstone pancreatitis, cholangitis and common bile duct stones.
Laparoscopic cholecystectomy, with achievement of the critical view of safety, is the standard surgical approach.
Patient-reported outcome measures (PROMs) and postoperative satisfaction have become increasingly important in the assessment of surgical outcomes and are considered key components of patient-centred care.
This study aims to assess pain management and quality of care during elective cholecystectomy at Limoges University Hospital.
Postoperative pain will be assessed using the visual analogue scale (VAS) two hours after surgery. Postoperative complications will be recorded and classified according to the Clavien-Dindo classification up to four weeks after surgery.
Intraoperative pain management techniques, including trocar-site infiltration, diaphragmatic dome infiltration with local anaesthetic and transversus abdominis plane (TAP) block, will also be documented.
Quality of life will be assessed before surgery (T0) and at postoperative follow-up (T2) using the GIQLI and EQ-5D-5L questionnaires. Patient experience will be evaluated at T2 using a study-specific PREMS questionnaire.
Data will be collected prospectively from clinical records and patient-completed questionnaires administered during the preoperative consultation and at the postoperative follow-up consultation, approximately 3 to 6 weeks after surgery.
The study is expected to contribute to the continuous improvement of pain management and quality of care for patients undergoing cholecystectomy at Limoges University Hospital.
Тип исследования
Регистрация (Оцененный)
Контакты и местонахождение
Контакты исследования
- Имя: Niki CHRISTOU, Professor
- Номер телефона: 05 55 05 55 55
- Электронная почта: niki.christou@chu-limoges.fr
Учебное резервное копирование контактов
- Имя: Oumar SECK
- Электронная почта: cheikhououmar.seck@chu-limoges.fr
Места учебы
-
-
-
Limoges, Франция, 87042
- Рекрутинг
- Chu Limoges
-
Контакт:
- Niki CHRISTOU, Professor
- Номер телефона: 05 55 05 55 55 0555058630
- Электронная почта: niki.christou@chu-limoges.fr
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Метод выборки
Исследуемая популяция
Patients undergoing elective cholecystectomy, laparoscopic surgery or minimally invasive surgery.
Описание
Inclusion Criteria:
- Age 18 years or older.
- Patients undergoing elective cholecystectomy.
- Patients undergoing laparoscopic surgery or minimally invasive surgery, including conversion to open laparotomy when necessary.
- Patients able to complete questionnaires independently or with the assistance of a caregiver.
- Patients covered by a health insurance scheme.
- Patients who have not objected to participation in the study.
Exclusion Criteria:
- Patients undergoing emergency surgery.
- Patients undergoing cholecystectomy when gallbladder removal is not the primary purpose of the surgical procedure.
- Patients with a history of chronic gastrointestinal disease.
- Patients with known gallbladder cancer.
- Patients scheduled for open laparotomy.
Учебный план
Как устроено исследование?
Детали дизайна
- Наблюдательные модели: COHORT
- Временные перспективы: PROSPECTIVE
Когорты и вмешательства
Группа / когорта |
|---|
|
Patients undergoing elective cholecystectomy
Adult patients undergoing elective cholecystectomy at Limoges University Hospital |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Proportion of patients with a visual analogue scale (VAS) pain
Временное ограничение: From two hours after surgery to four weeks postoperatively.
|
Proportion of patients with a visual analogue scale (VAS) pain score below 4 two hours after cholecystectomy, associated with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery. |
From two hours after surgery to four weeks postoperatively.
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Proportion of patients with a VAS pain score
Временное ограничение: Two hours after surgery.
|
Proportion of patients with a VAS pain score below 4 two hours after cholecystectomy. |
Two hours after surgery.
|
|
Proportion of patients experiencing early postoperative complications
Временное ограничение: Up to four weeks after surgery.
|
Proportion of patients experiencing early postoperative complications, classified according to the Clavien-Dindo classification. |
Up to four weeks after surgery.
|
|
Description of intraoperative pain management techniques
Временное ограничение: During surgery
|
Assessment of intraoperative analgesic techniques used during surgery, including: local anaesthetic infiltration at trocar insertion sites, local anaesthetic infiltration of the diaphragmatic dome, transversus abdominis plane (TAP) block . For each technique performed, the type of local anaesthetic used and the administered dose will be recorded, where applicable. |
During surgery
|
|
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score
Временное ограничение: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score between baseline (T0) and postoperative follow-up (T2) |
Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
|
Change in the EQ-5D-5L visual analogue scale (VAS)
Временное ограничение: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
Change in the EQ-5D-5L visual analogue scale (VAS), corresponding to the patient's self-rated health status today, between baseline (T0) and postoperative follow-up (T2). |
Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
|
Description of patient-reported experience using the study-specific PREMS questionnaire
Временное ограничение: Postoperative assessment at 3 to 6 weeks (T2)
|
Description of patient-reported experience using the study-specific PREMS questionnaire, analysed item by item. |
Postoperative assessment at 3 to 6 weeks (T2)
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Niki CHRISTOU, Professor, University Hospital, Limoges
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
- Боль
- Неврологические проявления
- Заболевания нервной системы
- Послеоперационные осложнения
- Патологические процессы
- Заболевания пищеварительной системы
- Нейроповеденческие проявления
- Заболевания желчевыводящих путей
- Заболевания желчного пузыря
- Расстройства восприятия
- Патологические состояния, признаки и симптомы
- Признаки и симптомы
- Боль, Послеоперационный
- Холецистит
- Агнозия
- Желчекаменная болезнь
Другие идентификационные номера исследования
- 87RI24_0064 (SATISCHOL)
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Описание плана IPD
Individual participant data collected during this study will not be made publicly available. Data will be handled in accordance with applicable data protection regulations and institutional policies.
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .